TQF3250 / Sino Biopharm - LARVOL DELTA

A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects (clinicaltrials.gov) - P1 | N=66 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

New P1 trial • Diabetes

…Sino Biopharmaceutical…announces that the clinical trial application for its self-developed innovative drug, TQF3250 capsules…has been approved by the China National Medical Products Administration (NMPA) and the United States Food and Drug Administration (FDA), intended for weight loss (HKEXnews)

IND • New trial • Obesity